Company intelligence / Profile preview

Restorsea

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

Restorsea's products using the proprietary Aquabeautine XL enzyme are clinically proven to reduce the appearance of brown spots, redness, and signs of aging, with better tolerability than glycolic acid according to published studies in peer-reviewed dermatology journals[1][2].

Therapeutic areas: Dermatology
Modalities: Protein
Industry: Non-Drug Biotech

Partnerships

Aqua Bio Technology ASA (ingredient supplier and technology licensor)[1][4][5]

Beyond the preview

Go deeper on Restorsea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Restorsea.

Explore the full profile